Raymond James analyst Justin Jenkins maintains Sunoco (NYSE:SUN) with a Outperform and raises the price target from $50 to $51.
Cantor Fitzgerald Initiates Coverage On Lipocine with Overweight Rating, Announces Price Target of $3
Cantor Fitzgerald analyst Jennifer Kim initiates coverage on Lipocine (NASDAQ:LPCN) with a Overweight rating and announces Price Target of $3.